Comprehensive genomic analysis of circulating tumor DNA for patients with advanced non-small cell lung cancer

被引：4

作者：

Lissa, Delphine ^{[1
]}

Robles, Ana I. ^{[2
]}

机构：

[1] NCI, Lab Human Carcinogenesis, NIH, Bethesda, MD 20892 USA

[2] NCI, Off Canc Clin Prote Res, NIH, Bethesda, MD 20892 USA

来源：

ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷 / 05期

关键词：

D O I：

10.21037/atm.2018.12.57

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 50 条

[31] Budget Impact Analysis of Comprehensive Genomic Profiling in Advanced Non-Small Cell Lung Cancer in Taiwan [J].

Tsai, Yi-Ling ;

Chang, Chee Jen .

VALUE IN HEALTH REGIONAL ISSUES, 2023, 35 :48-56

[32] EPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer [J].

Lindsay, C. R. ;

Blackhall, F. H. ;

Carmel, A. ;

Gazzaniga, P. ;

Groen, H. J. M. ;

Krebs, M. G. ;

Muinelo-Romay, L. ;

Pantel, K. ;

Rossi, E. ;

Terstappen, L. ;

Wikman, H. ;

Soria, J-C. ;

Farace, F. F. ;

Renehan, A. ;

Dive, C. ;

Besse, B. ;

Michiels, S. .

ANNALS OF ONCOLOGY, 2019, 30

[33] Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis [J].

Devriese, L. A. ;

Bosma, A. J. ;

van de Heuvel, M. M. ;

Heemsbergen, W. ;

Voest, E. E. ;

Schellens, J. H. M. .

LUNG CANCER, 2012, 75 (02) :242-247

[34] Circulating tumor cell analysis in patients with advanced non-small cell lung cancer treated with biweekly gemcitabine and docetaxel. [J].

Juan Vidal, O. ;

Fleitas, T. ;

Garde, J. ;

Munoz, J., Sr. ;

Martin, M. ;

Macia, S. ;

Catot, S. ;

Vidal, J. ;

Gomez-Codina, J. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)

[35] Impact of tumor genomic alterations on development of cancer cachexia in patients with advanced non-small cell lung cancer [J].

Fujii, Hiroyuki ;

Yoshida, Tatsuya ;

Shirasawa, Masayuki ;

Fujimoto, Kazushi ;

Mizuno, Takaaki ;

Sunami, Kuniko ;

Koyama, Takafumi ;

Motoi, Noriko ;

Shinno, Yuki ;

Okuma, Yusuke ;

Goto, Yasushi ;

Horinouchi, Hidehito ;

Yamamoto, Noboru ;

Ohe, Yuichiro .

ANNALS OF ONCOLOGY, 2023, 34 :S1430-S1430

[36] Predictive factors for detectability of genomic alterations from circulating cell-free DNA in patients with advanced non-small cell lung cancer [J].

Kimura, H. ;

Koba, H. ;

Kasahara, K. .

ANNALS OF ONCOLOGY, 2017, 28

[37] Real-World Clinical Outcomes after Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer [J].

Olsen, Steven ;

Liao, Jiemin ;

Hayashi, Hidetoshi .

CURRENT ONCOLOGY, 2022, 29 (07) :4811-4826

[38] Isolation of circulating tumor cells and potential heterogeneity analysis in advanced non-small cell lung cancer [J].

Zhang, H. ;

Zhang, Q. ;

Nong, J. ;

Wang, J. ;

Yan, Z. ;

Yi, L. ;

Cheng, X. ;

Liu, Z. ;

Zhang, S. .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) :S120-S121

[39] Preoperative Circulating Tumor DNA Status Predicts Pathological Response in Advanced Non-small Cell Lung Cancer [J].

Fu, R. ;

Xiong, Y. -Y. ;

Li, F. ;

Cai, M. ;

Chen, R. -R. ;

Li, H. -J. ;

Wu, Y. -L. ;

Zhong, W. -Z. .

JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :S599-S599

[40] Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer [J].

Marinello, Arianna ;

Tagliamento, Marco ;

Pagliaro, Arianna ;

Conci, Nicole ;

Cella, Eugenia ;

Vasseur, Damien ;

Remon, Jordi ;

Levy, Antonin ;

Dall'Olio, Filippo Gustavo ;

Besse, Benjamin .

CANCER TREATMENT REVIEWS, 2024, 129

← 1 2 3 4 5 →